Education
About Us
Working with TipRanks
Follow Us
Urologix (ULGX)
OTHER OTC:ULGX
| Jun 14 | Jun 13 | Jun 12 | Jun 11 | Jun 10 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | |||||
| Gross Profit | $ 6.09M | $ 8.18M | $ 8.38M | $ 6.54M | $ 8.20M |
| Operating Income | $ -4.00M | $ -4.53M | $ -4.14M | $ -3.73M | $ -2.26M |
| EBITDA | $ -3.41M | $ -3.86M | $ -3.45M | $ -3.16M | $ -1.46M |
| Net Income | $ -7.61M | $ -4.29M | $ -4.70M | $ -3.73M | $ -2.17M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ ― | $ ― | $ ― | $ ― | $ ― |
| Total Assets | $ 5.67M | $ 12.53M | $ 12.68M | $ 6.76M | $ 10.20M |
| Total Debt | $ 5.33M | $ 5.33M | $ 0.00 | $ 0.00 | $ 0.00 |
| Net Debt | $ 4.62M | $ 3.04M | $ -1.90M | $ -3.06M | $ -5.70M |
| Total Liabilities | $ 12.64M | $ 12.11M | $ 12.05M | $ 1.92M | $ 2.00M |
| Stockholders' Equity | $ ― | $ ― | $ ― | $ ― | $ ― |
| Cash Flow | |||||
| Free Cash Flow | $ -1.57M | $ -2.07M | $ -770.00K | $ -2.64M | $ -1.34M |
| Operating Cash Flow | $ -1.53M | $ -1.96M | $ -713.00K | $ -2.37M | $ -1.25M |
| Investing Cash Flow | |||||
| Financing Cash Flow |
Urologix Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.